News Headlines Article

Heart Attack Survival Better When Meds Are Free
HealthLeaders Media

Providing appropriate preventive drugs to patients free of charge following a heart attack would increase survival and save billions annually, a cost-effectiveness analysis found. Compared with usual coverage, providing beta-blockers, angiotensin-converting enzyme inhibitors (ACE I) or angiotensin receptor blockers (ARB), statins, and aspirin without cost to patients would result in greater quality-adjusted survival (0.14 quality-adjusted life years) and less cost ($4,011 savings) per patient.